Financial Instruments - Schedule of Available-for-Sale Securities (Details) - Cash, cash equivalents, and restricted cash - USD ($) $ in Thousands	Sep. 30, 2026	Dec. 31, 2025
Available-for-sale Securities
Amortized Cost	$ 1,097,195	$ 1,076,140
Gross Unrealized Gain	0	0
Gross Unrealized Loss	0	0
Estimated Fair Value	$ 1,097,195	$ 1,076,140